Compare · DHR vs JBTM
DHR vs JBTM
Side-by-side comparison of Danaher Corporation (DHR) and JBT Marel Corporation (JBTM): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both DHR and JBTM operate in Industrial Machinery/Components (Industrials), so they compete in similar markets.
- DHR is the larger of the two at $129.90B, about 20.1x JBTM ($6.45B).
- Over the past year, DHR is down 7.9% and JBTM is up 0.1% - JBTM leads by 8.0 points.
- DHR has been more active in the news (17 items in the past 4 weeks vs 13 for JBTM).
- DHR has more recent analyst coverage (25 ratings vs 4 for JBTM).
- Company
- Danaher Corporation
- JBT Marel Corporation
- Price
- $183.50-0.45%
- $124.15+0.02%
- Market cap
- $129.90B
- $6.45B
- 1M return
- +4.46%
- -10.03%
- 1Y return
- -7.90%
- +0.09%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NYSE
- NYSE
- IPO
- News (4w)
- 17
- 13
- Recent ratings
- 25
- 4
Danaher Corporation
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; cellular analysis, lab automation, and centrifugation instruments; microscopes; and genomics consumables. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology and molecular diagnostics products. This segment offers analytical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.
Latest DHR
- Sirius XM Holdings Set to Join S&P MidCap 400
- Danaher Corporation filed SEC Form 8-K: Other Events
- DZ Bank initiated coverage on Danaher with a new price target
- Wolfe Research resumed coverage on Danaher
- SCIEX Launches the novus V55 System With SCIEX OS 5.0 Software and AI Enablement Tools
- SCIEX Advances the ZenoTOF Line With Platform-Wide Expansions in Software, Integrations, and Key Collaborations
- Citigroup resumed coverage on Danaher with a new price target
- Henry Schein Announces the Election of William K. "Dan" Daniel as Independent Chairman of the Board
- SVP, Human Resources Couchara Georgeann covered exercise/tax liability with 281 shares, decreasing direct ownership by 3% to 8,291 units (SEC Form 4)
- Director Filler Linda was granted 680 shares, increasing direct ownership by 3% to 24,712 units (SEC Form 4)
Latest JBTM
- New insider Moller Andrew James claimed no ownership of stock in the company (SEC Form 3)
- Director Savage Ann was granted 1,232 shares, increasing direct ownership by 70% to 2,987 units (SEC Form 4)
- Director Masson Arnar Thor was granted 1,232 shares, increasing direct ownership by 14% to 9,761 units (SEC Form 4)
- Director Kawalek Polly B was granted 1,964 shares, increasing direct ownership by 3% to 76,024 units (SEC Form 4)
- Director Jackson Lawrence V was granted 1,232 shares, increasing direct ownership by 13% to 10,783 units (SEC Form 4)
- Director Harrington Charles L. was granted 1,964 shares, increasing direct ownership by 21% to 11,356 units (SEC Form 4)
- Director Gudmundsson Olafur S was granted 1,232 shares, increasing direct ownership by 12% to 11,212 units (SEC Form 4)
- Director Gronfeldt Svafa was granted 1,232 shares, increasing direct ownership by 65% to 3,132 units (SEC Form 4)
- Director Feldman Alan D was granted 1,232 shares, increasing direct ownership by 2% to 65,855 units (SEC Form 4)
- Director Brasier Barbara L was granted 1,232 shares, increasing direct ownership by 14% to 10,259 units (SEC Form 4)